Key Metrics
CiteScore 

7.8
H-Index 

35
Impact Factor 

5 - 10
SJR 

Q1Pharmacology (medical)

SNIP 

1.61
Recommended pre-submission checks
Powered by 

Topics Covered on European Heart Journal - Cardiovascular Pharmacotherapy
European Heart Journal - Cardiovascular Pharmacotherapy Journal Specifications
| Overview | |
| Publisher | OXFORD UNIV PRESS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in European Heart Journal - Cardiovascular Pharmacotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in European Heart Journal - Cardiovascular Pharmacotherapy
May the Universal Truth rest in peace and us with Her? On how to understand inconsistency in and among pharmacological trials.
- 5 Aug 2026
- European heart journal. Cardiovascular pharmacotherapy
Authors' reply to: "Stent-Free Is Not Risk-Free: Risk-Defined DAPT After DCB-Only PCI in ACS".
- 4 Aug 2026
- European heart journal. Cardiovascular pharmacotherapy
Correction to: Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio-renal-metabolic risk modulation.
- 28 Jul 2026
- European heart journal. Cardiovascular pharmacotherapy
From "bridging specialties" to "owning the patient": rethinking accountability in Cardiovascular-Kidney-Metabolic syndrome care.
- 27 Jul 2026
- European heart journal. Cardiovascular pharmacotherapy
Beyond API-CAT: The remaining challenges of extended anticoagulation for cancer-associated thrombosis.
- 22 Jul 2026
- European heart journal. Cardiovascular pharmacotherapy
Reply to Zhang and Lou: beta-blockers after myocardial infarction should be guided by indication, ejection fraction, and contemporary evidence.
- 17 Jul 2026
- European heart journal. Cardiovascular pharmacotherapy
May the Universal Truth rest in peace and us with Her? On how to understand inconsistency in and among pharmacological trials.
- 5 Aug 2026
- European heart journal. Cardiovascular pharmacotherapy
Authors' reply to: "Stent-Free Is Not Risk-Free: Risk-Defined DAPT After DCB-Only PCI in ACS".
- 4 Aug 2026
- European heart journal. Cardiovascular pharmacotherapy
Correction to: Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio-renal-metabolic risk modulation.
- 28 Jul 2026
- European heart journal. Cardiovascular pharmacotherapy
From "bridging specialties" to "owning the patient": rethinking accountability in Cardiovascular-Kidney-Metabolic syndrome care.
- 27 Jul 2026
- European heart journal. Cardiovascular pharmacotherapy
Beyond API-CAT: The remaining challenges of extended anticoagulation for cancer-associated thrombosis.
- 22 Jul 2026
- European heart journal. Cardiovascular pharmacotherapy
Reply to Zhang and Lou: beta-blockers after myocardial infarction should be guided by indication, ejection fraction, and contemporary evidence.
- 17 Jul 2026
- European heart journal. Cardiovascular pharmacotherapy